back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-11-11 13:49 Tx date 2024-11-11 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,000
+20,000 vol $5.15 each |
278,278 | |
| Filed 2024-11-05 17:05 Tx date 2024-11-01 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$719.31
+5 vol $143.86 each |
7,029 | |
| Filed 2024-10-31 21:06 Tx date 2024-10-28 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$22,552
+158 vol $142.74 each |
7,024 | |
| Filed 2024-09-18 14:19 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,798
+497 vol $5.63 each |
258,278 | |
| Filed 2024-09-18 14:19 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,516
+2,291 vol $5.90 each |
257,781 | |
| Filed 2024-08-06 19:25 Tx date 2024-08-02 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$650.39
+5 vol $130.08 each |
6,866 | |
| Filed 2024-08-02 13:58 Tx date 2024-07-29 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$22,554
+173 vol $130.37 each |
6,861 | |
| Filed 2024-06-19 21:05 Tx date 2024-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,178
+609 vol $5.22 each |
255,490 | |
| Filed 2024-06-19 21:03 Tx date 2024-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,025
+2,595 vol $5.79 each |
254,881 | |
| Filed 2024-05-07 14:00 Tx date 2024-05-03 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$693.69
+6 vol $115.61 each |
6,688 | |
| Filed 2024-05-03 19:22 Tx date 2024-04-29 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$22,625
+197 vol $114.85 each |
6,682 | |
| Filed 2024-04-25 14:01 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$715,000
+125,000 vol $5.72 each |
1,450,022 | |
| Filed 2024-04-25 14:00 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$715,000
+125,000 vol $5.72 each |
1,325,022 | |
| Filed 2024-04-25 14:00 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,925,546
+336,634 vol $5.72 each |
1,200,022 | |
| Filed 2024-04-16 18:08 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
||
| Filed 2024-04-16 18:07 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
||
| Filed 2024-04-16 18:06 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,910,702
+335,211 vol $5.70 each |
||
| Filed 2024-04-16 18:10 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$658,982
+115,611 vol $5.70 each |
273,499 | |
| Filed 2024-04-16 18:08 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
1,448,599 | |
| Filed 2024-04-16 18:07 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
1,323,599 | |
| Filed 2024-04-16 18:06 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,910,702
+335,211 vol $5.70 each |
1,198,599 | |
| Filed 2024-04-05 16:11 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$281,414
+53,097 vol $5.30 each |
252,286 | |
| Filed 2024-04-05 16:09 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-299,998.05
-53,097 vol $5.65 each |
157,888 | |
| Filed 2024-03-19 20:22 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,341
+2,706 vol $5.30 each |
199,189 | |
| Filed 2024-02-06 18:01 Tx date 2024-02-02 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$297.99
+3 vol $99.33 each |
6,485 | |
| Filed 2024-02-01 11:13 Tx date 2024-01-29 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$101,340
+1,013 vol $100.04 each |
6,482 | |
| Filed 2023-12-19 10:39 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$16,728
+3,217 vol $5.20 each |
196,483 | |
| Filed 2023-11-07 15:49 Tx date 2023-11-03 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$286.03
+3 vol $95.34 each |
5,469 | |
| Filed 2023-11-01 15:47 Tx date 2023-10-30 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$21,302
+223 vol $95.53 each |
5,466 | |
| Filed 2023-09-19 11:27 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,723
+3,331 vol $4.42 each |
193,266 | |
| Filed 2023-08-08 14:34 Tx date 2023-08-04 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$345.01
+4 vol $86.25 each |
5,243 | |
| Filed 2023-08-02 13:22 Tx date 2023-07-31 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$21,240
+240 vol $88.50 each |
5,239 | |
| Filed 2023-06-19 13:43 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,965
+3,245 vol $4.92 each |
189,935 | |
| Filed 2023-05-24 12:32 Tx date 2023-05-24 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$95,000
+20,000 vol $4.75 each |
186,690 | |
| Filed 2023-05-09 18:16 Tx date 2023-05-05 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$336.44
+4 vol $84.11 each |
4,999 | |
| Filed 2023-05-04 16:19 Tx date 2023-05-01 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$21,246
+251 vol $84.65 each |
4,995 | |
| Filed 2023-04-02 23:53 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$391,030
+88,070 vol $4.44 each |
210,985 | |
| Filed 2023-04-02 23:51 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$419,886
+94,569 vol $4.44 each |
863,388 | |
| Filed 2023-03-19 23:01 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,174
+2,614 vol $5.04 each |
166,690 | |
| Filed 2023-02-07 16:26 Tx date 2023-02-03 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$239.64
+3 vol $79.88 each |
4,744 | |
| Filed 2023-02-02 16:16 Tx date 2023-01-30 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$96,180
+1,160 vol $82.91 each |
4,741 | |
| Filed 2022-12-23 15:55 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,701
+321 vol $5.30 each |
164,076 | |
| Filed 2022-12-23 15:54 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,057
+2,459 vol $5.31 each |
163,755 | |
| Filed 2022-11-08 13:52 Tx date 2022-11-04 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$242.85
+3 vol $80.95 each |
3,581 | |
| Filed 2022-11-02 19:26 Tx date 2022-10-31 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$21,237
+260 vol $81.68 each |
3,578 | |
| Filed 2022-10-07 11:27 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,185
+2,342 vol $5.63 each |
161,296 | |
| Filed 2022-09-21 16:29 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$22,401
+3,979 vol $5.63 each |
||
| Filed 2022-09-21 16:29 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$22,401
+3,979 vol $5.63 each |
162,933 | |
| Filed 2022-08-16 16:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
689,387 | |
| Filed 2021-12-10 14:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
||
| Filed 2021-12-10 13:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
||
| Filed 2021-05-20 12:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
| Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
| Filed 2022-08-09 16:41 Tx date 2022-08-05 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$154.46
+2 vol $77.23 each |
3,318 | |
| Filed 2022-08-04 22:57 Tx date 2022-08-01 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$21,291
+274 vol $77.70 each |
3,316 | |
| Filed 2022-06-20 14:22 Tx date 2022-06-20 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,998
+19,455 vol $5.14 each |
158,954 | |
| Filed 2022-06-17 21:37 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,433
+2,765 vol $5.22 each |
139,499 | |
| Filed 2022-05-18 14:48 Tx date 2022-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,999
+19,305 vol $5.18 each |
136,734 | |
| Filed 2022-05-17 13:46 Tx date 2022-05-06 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$143.00
+2 vol $71.50 each |
3,042 | |
| Filed 2022-05-10 12:58 Tx date 2022-05-06 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$214.50
+3 vol $71.50 each |
||
| Filed 2022-05-10 12:58 Tx date 2022-05-06 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$214.50
+3 vol $71.50 each |
3,043 | |
| Filed 2022-03-30 16:06 Tx date 2022-03-30 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$103,600
+20,000 vol $5.18 each |
117,429 | |
| Filed 2022-03-29 09:41 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$413,840
+79,432 vol $5.21 each |
768,819 | |
| Filed 2022-03-29 09:37 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$363,751
+69,818 vol $5.21 each |
122,915 | |
| Filed 2022-03-28 16:48 Tx date 2022-03-22 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,214
+2,054 vol $5.46 each |
97,429 | |
| Filed 2022-02-08 14:42 Tx date 2022-02-04 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$65.42
+1 vol $65.42 each |
2,750 | |
| Filed 2022-02-01 15:56 Tx date 2022-01-31 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$91,770
+1,470 vol $62.43 each |
2,749 | |
| Filed 2021-12-17 18:24 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,470
+2,389 vol $5.22 each |
95,375 | |
| Filed 2021-12-14 14:00 Tx date 2021-12-14 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,840
+9,200 vol $5.20 each |
92,986 | |
| Filed 2021-12-13 21:58 Tx date 2021-12-13 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$82,160
+15,800 vol $5.20 each |
83,786 | |
| Filed 2021-12-10 14:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
689,387 | |
| Filed 2021-12-10 13:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
689,387 | |
| Filed 2021-12-10 13:06 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,374 vol |
||
| Filed 2021-05-20 12:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
| Filed 2021-05-20 12:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
| Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
| Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
| Filed 2021-11-24 10:01 Tx date 2021-11-23 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,375
+7,500 vol $5.25 each |
67,986 | |
| Filed 2021-11-09 14:25 Tx date 2021-11-05 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$56.37
+1 vol $56.37 each |
1,279 | |
| Filed 2021-11-02 22:25 Tx date 2021-11-01 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$16,704
+298 vol $56.06 each |
1,278 | |
| Filed 2021-09-17 17:47 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,754
+2,402 vol $5.31 each |
60,486 | |
| Filed 2021-09-15 09:49 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+2,000 vol $5.25 each |
58,084 | |
| Filed 2021-08-09 17:16 Tx date 2021-08-06 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$58.75
+1 vol $58.75 each |
980 | |
| Filed 2021-08-04 18:17 Tx date 2021-08-02 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$8,179
+139 vol $58.85 each |
979 | |
| Filed 2021-07-02 17:03 Tx date 2021-07-02 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,956
+1,900 vol $5.24 each |
56,084 | |
| Filed 2021-06-22 18:02 Tx date 2021-06-09 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$46,831
+840 vol $55.75 each |
840 | |
| Filed 2021-06-16 16:52 Tx date 2021-06-09 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$46,832
+878 vol $53.34 each |
||
| Filed 2021-06-18 19:52 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,529
+1,998 vol $5.27 each |
54,184 | |
| Filed 2021-06-16 16:52 Tx date 2021-06-09 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$46,832
+878 vol $53.34 each |
878 | |
| Filed 2021-06-16 16:49 Tx date 2021-06-09 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-26 15:04 Tx date 2021-05-26 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,015
+1,915 vol $5.23 each |
52,186 | |
| Filed 2021-05-24 15:33 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$299,998
+53,097 vol $5.65 each |
53,097 | |
| Filed 2021-05-20 12:36 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
||
| Filed 2021-05-20 10:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
||
| Filed 2021-05-20 12:36 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
53,097 | |
| Filed 2021-05-20 12:33 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 12:32 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
689,404 | |
| Filed 2021-05-20 10:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
||
| Filed 2021-05-20 10:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$299,998
+53,097 vol $5.65 each |
53,097 | |
| Filed 2021-05-20 10:55 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 10:55 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
||
| Filed 2021-05-20 10:55 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+61,391 vol |
689,404 | |
| Filed 2021-04-06 08:33 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,740
+1,866 vol $5.22 each |
50,271 | |
| Filed 2021-01-13 16:08 Tx date 2021-01-13 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,240
+1,750 vol $5.28 each |
48,405 | |
| Filed 2020-12-21 18:59 Tx date 2020-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,352
+1,576 vol $5.30 each |
46,655 | |
| Filed 2020-09-28 16:50 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,742
+1,613 vol $6.04 each |
45,079 | |
| Filed 2020-07-03 16:18 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+135,556 vol |
628,013 | |
| Filed 2020-06-19 10:29 Tx date 2020-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,354
+1,180 vol $7.08 each |
43,466 | |
| Filed 2020-03-16 11:51 Tx date 2020-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,712
+1,608 vol $6.04 each |
42,286 | |
| Filed 2019-12-18 11:15 Tx date 2019-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,321
+1,092 vol $7.62 each |
40,678 | |
| Filed 2019-09-18 11:47 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,707
+1,251 vol $7.76 each |
39,586 | |
| Filed 2019-06-28 17:22 Tx date 2019-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,572
+1,128 vol $7.60 each |
38,335 | |
| Filed 2019-06-28 17:19 Tx date 2018-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,211
+872 vol $8.27 each |
22,327 | |
| Filed 2019-06-05 10:25 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+201 vol |
22,388 | |
| Filed 2019-06-04 14:45 Tx date 2019-05-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+201 vol |
||
| Filed 2019-06-04 14:46 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,209
+960 vol $7.51 each |
23,147 | |
| Filed 2019-06-04 14:45 Tx date 2019-05-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+201 vol |
36,335 | |
| Filed 2019-06-04 14:43 Tx date 2019-03-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$883,108
+115,138 vol $7.67 each |
492,457 | |
| Filed 2019-03-20 Tx date 2019-03-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,999
+12,987 vol $7.70 each |
35,174 | |
| Filed 2019-01-17 Tx date 2018-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,178
+732 vol $8.44 each |
22,187 | |
| Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
||
| Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
47,730 | |
| Filed 2018-07-18 Tx date 2018-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,175
+770 vol $8.02 each |
21,455 | |
| Filed 2018-06-18 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,830
+16,500 vol $1.02 each |
33,000 | |
| Filed 2018-05-28 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,070
+886 vol $7.98 each |
20,685 | |
| Filed 2018-05-28 Tx date 2018-03-20 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$908,259
+117,498 vol $7.73 each |
377,319 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,730 | |
| Filed 2018-01-15 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,058
+793 vol $7.64 each |
19,799 | |
| Filed 2017-10-06 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,063
+810 vol $8.72 each |
19,006 | |
| Filed 2017-07-03 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,067
+719 vol $9.83 each |
18,196 | |
| Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+18,500 vol |
27,730 | |
| Filed 2017-04-27 Tx date 2017-03-06 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-27 Tx date 2017-04-25 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,005
+16,500 vol $0.97 each |
16,500 | |
| Filed 2017-04-03 Tx date 2017-03-31 |
$ATE
Antibe Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
575,000 | |
| Filed 2017-03-28 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,056
+584 vol $10.37 each |
17,477 | |
| Filed 2017-03-28 Tx date 2017-03-21 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$351,692
+34,821 vol $10.10 each |
259,821 | |
| Filed 2016-12-22 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+10,000 vol $10.00 each |
16,893 | |
| Filed 2016-10-03 Tx date 2016-09-29 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,230 vol |
9,230 | |
| Filed 2016-10-03 Tx date 2016-09-29 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-30 Tx date 2016-09-29 |
$CTX
Crescita Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
13,778 | ||
| Filed 2016-09-23 Tx date 2016-09-21 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,160,000
+225,000 vol $9.60 each |
225,000 | |
| Filed 2016-09-23 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-31 Tx date 2016-08-31 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,893 | ||
| Filed 2016-03-24 Tx date 2015-11-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-24 Tx date 2016-03-23 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+9,231 vol |
9,231 | |
| Filed 2016-03-11 Tx date 2016-03-09 |
$ATE
Antibe Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,250
+250,000 vol $0.145 each |
375,000 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-32 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-3,778 vol |
32 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$14,273,284
+3,778 vol $3,778 each |
13,778 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+3,810 vol |
3,810 | |
| Filed 2016-01-06 Tx date 2015-11-03 |
$NRI
Nuvo Research Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-06 Tx date 2016-01-04 |
$NRI
Nuvo Research Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$52,000
+10,000 vol $5.20 each |
10,000 | |
| Filed 2016-01-06 Tx date 2015-11-03 |
$NRI
Nuvo Research Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-24 Tx date 2015-07-13 |
$ATE
Antibe Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,000
+50,000 vol $0.14 each |
125,000 |